Laboratory and clinical reliability of conformally coated subretinal implants.

Despite recent developments and new treatments in ophthalmology there is nothing available to cure retinal degenerations like Retinitis Pigmentosa (RP) yet. One of the most advanced approaches to treat people that have gone blind due to RP is to replace the function of the degenerated photoreceptors by a microelectronic neuroprosthetic device. Basically, this subretinal active implant transforms the incoming light into electric pulses to stimulate the remaining cells of the retina.

A new system for the treatment of retinal degeneration.

Recent clinical studies indicate that stimulation of the retina with tiny amounts of current can have a therapeutic effect on retinal diseases such as retinitis pigmentosa. We have therefore developed a preventive treatment system which stimulates the eye with a thread electrode; among other objectives, the aim is that even blind patients can administer the therapy themselves under physician's supervision.